Observational study finds environmental exposure to picloram linked to early-onset colorectal cancer — Evidence Review

A new study suggests that environmental exposures, notably the herbicide picloram, leave epigenetic marks associated with rising rates of early-onset colorectal cancer (EOCRC) in adults under 50. Related research broadly supports the role of environmental and lifestyle factors in this trend, aligning with the new findings from the Nature Medicine publication.

• Multiple large-scale studies have documented increasing EOCRC incidence globally, particularly in high-income regions, and attribute these trends to early-life environmental and lifestyle exposures rather than hereditary genetic mutations alone 1 2 3 4.
• Prior research has identified common risk factors for EOCRC, such as Western dietary patterns, obesity, physical inactivity, antibiotic use, and exposure to certain chemicals, but has struggled to pinpoint specific modifiable environmental risks—making the new identification of picloram particularly notable 4 7 9.
• The current study builds on earlier work linking epigenetic changes to environmental exposures, suggesting that methylation signatures can help trace cancer risk back to specific chemicals, a step forward in understanding EOCRC etiology 6 7 8.

Study Overview and Key Findings

Emerging evidence of a rising incidence of colorectal cancer among adults younger than 50 has prompted concern and investigation into non-genetic causes. Unlike late-onset cases, early-onset colorectal cancer lacks distinct genomic alterations, leading researchers to explore environmental and lifestyle factors that may leave detectable biological signatures. This study, conducted by the Vall d’Hebron Institute of Oncology and collaborators, is the first to use epigenetic markers—specifically DNA methylation patterns—to track the "exposome footprint" in EOCRC, focusing on how exposures such as diet, smoking, and pesticides may contribute to cancer risk. A key finding was the association between the herbicide picloram and increased EOCRC incidence, supported by both molecular and population-level analyses.

Property	Value
Study Year	2026
Organization	Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital
Journal Name	Nature Medicine
Authors	Silvana C. E. Maas, Iosune Baraibar, Lea Lemler, Maria Butjosa-Espín, Odei Blanco Irazuegui, Josep Tabernero, Elena Elez, Jose A. Seoane
Population	Patients with early-onset colorectal cancer
Methods	Observational Study
Outcome	Epigenetic signatures linked to environmental exposures
Results	Exposure to picloram correlated with early-onset colorectal cancer.

Literature Review: Related Studies

To situate the new findings in a broader scientific context, we searched the Consensus database—comprising over 200 million research papers—using targeted queries. The following search queries were used:

1. colorectal cancer young adults environment
2. picloram exposure cancer risk factors
3. early-onset colorectal cancer environmental causes

Below, related studies are summarized by key thematic questions:

Topic	Key Findings
What environmental and lifestyle factors drive rising EOCRC rates?	• EOCRC incidence is rising globally, especially in high-income countries, likely due to early-life exposures including Western diet, obesity, sedentary behavior, antibiotic use, and environmental agents 1 2 3 4 7 8 10. • Most EOCRC cases are not linked to family history or hereditary syndromes, emphasizing non-genetic risk factors 2 5 8 10.
How do epigenetic mechanisms link exposures to colorectal cancer risk?	• Epigenetic changes, such as DNA methylation, are influenced by environmental and lifestyle factors and may mediate cancer risk 4 6 7. • The new study uniquely uses methylation signatures to retrospectively indicate exposure to specific agents, such as picloram 6.
What is the evidence for specific chemical exposures (e.g., pesticides) in EOCRC?	• The new study identifies picloram as a potential risk factor for EOCRC, supported by population-level and molecular data 6. • Previous studies have implicated multiple chemicals, but direct links between individual pesticides and EOCRC remain limited; this research advances the field 4 6 9.
What are the clinical and epidemiological characteristics of EOCRC?	• EOCRC often presents at a more advanced stage, with distinct pathological features compared to late-onset CRC 5 8. • The trend has implications for screening and prevention strategies, as traditional risk models based on age and family history may miss many at-risk individuals 2 3 8 10.

What environmental and lifestyle factors drive rising EOCRC rates?

A consistent finding across multiple studies is the sharp rise in EOCRC in high-income countries, starting in the mid-1990s, with the majority of cases lacking a hereditary basis. Lifestyle and environmental exposures—including dietary patterns, obesity, inactivity, and chemical exposures—are frequently cited as likely contributors. The new study's identification of an environmental chemical (picloram) as a risk factor is in line with calls for investigating non-genetic, modifiable exposures.

• EOCRC rates have increased in at least nine high-income countries, often without a parallel rise in older populations, suggesting generational shifts in risk factors 1 3 4.
• Nonhereditary cases dominate EOCRC, with only 20–30% attributable to hereditary or familial syndromes 2 5 8 10.
• Behavioral and nutritional trends, such as increased intake of processed foods, reduced physical activity, and greater use of antibiotics and chemicals, have been proposed as drivers 4 7 8.
• The new study supports this body of evidence by linking specific, measurable exposures to disease risk via epigenetic markers 6.

How do epigenetic mechanisms link exposures to colorectal cancer risk?

Epigenetic modifications, especially DNA methylation, are increasingly recognized as mediators between environmental exposures and disease. The current study leverages methylation patterns as biomarkers to trace back to exposures, a novel approach that helps clarify causality in EOCRC risk.

• Environmental and lifestyle exposures can alter DNA methylation, impacting gene expression and potentially leading to carcinogenesis 4 7.
• Epigenetic signatures offer a retrospective means to assess cumulative exposure, overcoming limitations of self-reported behavior or incomplete exposure histories 6 7.
• The use of methylation risk scores in the new study provides evidence that such molecular footprints can distinguish EOCRC from late-onset CRC 6.
• This approach complements prior work that has linked epigenetic changes to factors like diet, smoking, and microbiome alterations 7 8.

What is the evidence for specific chemical exposures (e.g., pesticides) in EOCRC?

While epidemiological data have long suggested a connection between environmental chemicals and cancer risk, direct evidence for specific agents in EOCRC has been limited. The identification of picloram as a risk factor, both through epigenetic analysis and epidemiological association, marks a significant advance.

• Previous studies have implicated chemical exposures, including pesticides, as possible contributors, but have not pinpointed individual agents with strong evidence 4 9.
• The new study’s association between picloram exposure and EOCRC is supported by both molecular (epigenetic) and population-level data 6.
• This finding suggests that early-life or cumulative exposure to certain chemicals may play a more substantial role than previously recognized 6 9.
• The results provide a basis for further investigation into environmental regulations and preventive strategies 6 9.

What are the clinical and epidemiological characteristics of EOCRC?

EOCRC is often diagnosed at a later stage and tends to have distinct pathological features compared to older-onset cases. The rise in incidence has prompted discussions about updating screening guidelines and developing targeted prevention strategies.

• EOCRC is typically more advanced at diagnosis, with poorer differentiation and a higher prevalence of certain tumor subtypes 5 8.
• The majority of EOCRC patients do not meet classic risk criteria based on age or family history, presenting challenges for current screening models 2 3 8 10.
• The new study’s findings support the need to consider environmental and lifestyle exposures in risk assessment and public health policy 6.
• Mortality trends differ by age group, with younger patients not experiencing the same mortality declines seen in older adults 3 8.

Future Research Questions

While the new study provides important evidence linking environmental exposures and epigenetic changes to EOCRC risk, significant questions remain. Further research is needed to confirm causality, clarify mechanisms, explore population differences, and guide effective prevention strategies.

Research Question	Relevance
Does picloram exposure directly cause epigenetic changes that promote colorectal cancer?	Establishing a causal link is critical for regulatory and public health decisions. Experimental studies could confirm whether picloram exposure leads to specific DNA methylation changes associated with cancer risk 6 9.
What is the relative contribution of different environmental exposures to early-onset colorectal cancer risk?	Quantifying the impact of various exposures (diet, pesticides, antibiotics, physical inactivity) can help prioritize interventions and inform future screening guidelines 1 2 4 7 9.
How do epigenetic signatures differ between early-onset and late-onset colorectal cancer?	Understanding these differences may clarify why EOCRC rates are rising and could lead to the development of biomarkers for early detection or prevention 6 7 8.
Can interventions that reduce exposure to identified risk factors decrease the incidence of early-onset colorectal cancer?	Demonstrating that reducing exposure to agents like picloram or other modifiable risk factors lowers EOCRC incidence would support targeted public health and policy measures 4 6.
Are there population subgroups with greater susceptibility to environmental exposures linked to EOCRC?	Identifying genetic, demographic, or socioeconomic groups at higher risk could improve targeted screening and prevention, and address health disparities 2 8 9 10.